| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 6.648 | 35.225 | 55.554 | 55.396 | 60.569 | 60.329 | 76.624 | 66.758 |
| Total Income - EUR | - | - | 6.696 | 35.287 | 55.609 | 58.774 | 63.819 | 60.366 | 76.654 | 66.776 |
| Total Expenses - EUR | - | - | 11.205 | 51.857 | 53.762 | 46.433 | 55.794 | 59.557 | 73.178 | 97.323 |
| Gross Profit/Loss - EUR | - | - | -4.510 | -16.570 | 1.847 | 12.341 | 8.025 | 809 | 3.477 | -30.547 |
| Net Profit/Loss - EUR | - | - | -4.630 | -16.904 | 1.291 | 11.849 | 7.587 | 416 | 2.894 | -31.614 |
| Employees | - | - | 2 | 3 | 3 | 3 | 4 | 4 | 4 | 4 |
Check the financial reports for the company - Rehabromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 79 | 11.449 | 9.681 | 14.228 | 11.622 | 9.361 | 7.043 | 142.679 |
| Current Assets | - | - | 1.908 | 1.771 | 3.543 | 8.739 | 4.278 | 3.337 | 10.880 | 7.834 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 1.507 | 1.664 | 1.450 | 2.406 | 1.752 | 1.757 | 2.235 | 3.131 |
| Cash | - | - | 401 | 107 | 2.093 | 6.333 | 2.525 | 1.580 | 8.645 | 4.702 |
| Shareholders Funds | - | - | -4.586 | -21.405 | -19.716 | -7.493 | 260 | 677 | 3.569 | -28.065 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 8.111 | 34.725 | 34.494 | 32.010 | 15.706 | 12.088 | 14.388 | 179.416 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Rehabromed Srl